PUBLIC CONTRACT · 2017

FI0222/2017 - Ustecinumab 130 mg (5 mg/ml frs 26 ml) sol inj

Contract value: €5,367.60
Signed on: 6 March 2017
Procedure: Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 3443904

PUBLISHED SUBJECT

FI0222/2017 - USTECINUMAB 130 MG (5 MG/ML FRS 26 ML) SOL INJ

Parties involved

Contracting body: Centro Hospitalar Barreiro Montijo, E. P. E.
Awardee: JANSSEN CILAG FARMACEUTICA, LDA
Place of performance: Portugal, Setúbal, Barreiro
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: JANSSEN CILAG FARMACEUTICA, LDA · Tax ID 500189412

Values and timeline

Contract price: €5,367.60
Procedure base price: €5,367.60
Total effective price: €5,367.60
Publication date: 20 June 2017
Award date: 6 March 2017
Signing date: 6 March 2017
Performance period: 20 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion: Not stated
CPV code: 33600000-6 - Produtos farmacêuticos
Legal basis: Artigo 259.º do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos (DL 18/2008)
Framework agreement: CONCURSO PÚBLICO PARA A CELEBRAÇÃO DE CONTRATOS PÚBLICOS DE APROVISIONAMENTO PARA AQUISIÇÃO MEDICAMENTOS DO FORO ONCOLÓGICO II
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 2802778

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts